These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 17426205)

  • 81. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
    J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
    J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ; Lee VK; Loo SW
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Laryngeal sarcoidosis detected by FDG positron emission tomography.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
    Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
    J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Usefulness of 18F-α-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer.
    Kaira K; Higuchi T; Sunaga N; Arisaka Y; Hisada T; Tominaga H; Oriuchi N; Asao T; Tsushima Y; Yamada M
    Anticancer Res; 2016 Dec; 36(12):6481-6490. PubMed ID: 27919971
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    Furuya S; Naya M; Manabe O; Hirata K; Ohira H; Aikawa T; Koyanagawa K; Magota K; Tsujino I; Anzai T; Kuge Y; Oyama-Manabe N; Kudo K; Shiga T; Tamaki N
    J Nucl Cardiol; 2021 Oct; 28(5):2141-2148. PubMed ID: 31820409
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography.
    Rahmi A; Deshayes E; Maucort-Boulch D; Varron L; Grange JD; Kodjikian L; Seve P
    Br J Ophthalmol; 2012 Jan; 96(1):99-103. PubMed ID: 21464036
    [TBL] [Abstract][Full Text] [Related]  

  • 91. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
    Braun JJ; Kessler R; Constantinesco A; Imperiale A
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
    [TBL] [Abstract][Full Text] [Related]  

  • 92. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
    Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
    J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis.
    Seve P; Billotey C; Janier M; Grange JD; Broussolle C; Kodjikian L
    Ocul Immunol Inflamm; 2009; 17(3):179-84. PubMed ID: 19585360
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Utility of
    Chen H; Jin R; Wang Y; Li L; Li K; He Y
    Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
    Rastogi A; Bhattacharya A; Prakash M; Sharma S; Mittal BR; Khandelwal N; Bhansali A
    Nucl Med Commun; 2016 Dec; 37(12):1253-1259. PubMed ID: 27749777
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    Gholamrezanezhad A; Mehta L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(3):172-174. PubMed ID: 28526323
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
    Nobusawa A; Kim M; Kaira K; Miyashita G; Negishi A; Oriuchi N; Higuchi T; Tsushima Y; Kanai Y; Yokoo S; Oyama T
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1692-700. PubMed ID: 23801167
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diagnostic usefulness of an amino acid tracer, α-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies.
    Nishii R; Higashi T; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Motoyama H; Kawakami K; Nakaoku T; Nohara J; Okamura M; Watanabe T; Nakatani K; Nagamachi S; Tamura S; Kawai K; Kobayashi M
    Ann Nucl Med; 2013 Nov; 27(9):808-21. PubMed ID: 23824782
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.